Challenges in understanding host genetics and severity of community-acquired pneumonia
- Jordi Solé-Violán1,2,15,
- Elisa Hernández-Brito3,4,15,
- José Manuel Valencia5,
- Estefanía Herrera-Ramos4,
- Luis Borderías6,
- M. Luisa Briones7,
- Olga Rajas8,
- Jorge Freixinet9,
- Leonardo Lorente10,
- Antoni Payeras11,
- Jose Ferreres12,
- Nieves Carbonell12,
- Nereida González-Quevedo3,
- Jesús M. González-Martín13,
- Felipe Rodríguez de Castro4,5 and
- Carlos Rodríguez-Gallego3,14⇑
- 1Intensive Care Unit, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
- 2CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
- 3Department of Immunology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
- 4Department of Medical and Surgical Sciences, School of Medicine, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
- 5Department of Respiratory Diseases, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
- 6Department of Respiratory Diseases, Hospital San Jorge, Huesca, Spain
- 7Department of Respiratory Diseases, Hospital Clínico y Universitario de Valencia, Valencia, Spain
- 8Department of Respiratory Diseases, Hospital Universitario de la Princesa, Madrid, Spain
- 9Department of Thoracic Surgery, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
- 10Intensive Care Unit, Hospital Universitario de Canarias, La Laguna, Spain
- 11Department of Internal Medicine, Hospital Son Llatzer, Palma de Mallorca, Spain
- 12Intensive Care Unit, Hospital Clínico y Universitario de Valencia, Valencia, Spain
- 13Biostatistics Division, Research Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain
- 14University Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain
- 15These authors contributed equally to this work
- Dr Carlos Rodríguez-Gallego. E-mail: jrodgal{at}gobiernodecanarias.org
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. SOLE-VIOLAN has nothing to disclose.
Conflict of interest: Ms. HERNANDEZ-BRITO has nothing to disclose.
Conflict of interest: Dr. VALENCIA-GALLARDO has nothing to disclose.
Conflict of interest: Dr. Herrera-Ramos has nothing to disclose.
Conflict of interest: Dr. Borderias reports personal fees, non-financial support and other from GSK, personal fees from Allergy Therapeutics, non-financial support from Novartis, non-financial support from Boehringer, non-financial support from Esteve Teijin, personal fees from Astra Zeneca, non-financial support from Menarini, outside the submitted work.
Conflict of interest: Dra. Briones Urtiaga has nothing to disclose.
Conflict of interest: Dra. RAJAS has nothing to disclose.
Conflict of interest: Dr. FREIXENET has nothing to disclose.
Conflict of interest: Dr. LORENTE has nothing to disclose.
Conflict of interest: Dr. Payeras has nothing to disclose.
Conflict of interest: Dr. FERRERES has nothing to disclose.
Conflict of interest: Dra. CARBONELL has nothing to disclose.
Conflict of interest: Ms. González-Quevedo has nothing to disclose.
Conflict of interest: Sir González-Martin has nothing to disclose.
Conflict of interest: Dr. Rodríguez de Castro has nothing to disclose.
Conflict of interest: Dr. RODRÍGUEZ-GALLEGO has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received October 11, 2020.
- Copyright ©ERS 2020
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.